Efficacy and Safety Study of Z160 in Subjects With Postherpetic Neuralgia
NCT01757873 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 144
Last updated 2013-12-12
Summary
This study will compare Z160 and placebo in patients with Postherpetic Neuralgia for safety and efficacy for a period of 6 weeks.
Conditions
- Postherpetic Neuralgia
Interventions
- DRUG
-
Z160
- DRUG
Sponsors & Collaborators
-
Zalicus
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-12-31
- Primary Completion
- 2013-11-30
- Completion
- 2013-11-30
Countries
- United States
Study Locations
More Related Trials
-
NGX-4010 for the Treatment of Postherpetic Neuralgia
NCT00061776 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Preliminary Efficacy of MK0759 in Postherpetic Neuralgia (PHN)(0759-004)
NCT00245544 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Determine if an Investigational Pain Medicine Provides Relief of Chronic Pain After a Shingles Outbreak
NCT00506610 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Comparative Study of KHK6188
NCT01544296 ·Status: COMPLETED ·Phase: PHASE2
-
A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN)
NCT00576108 ·Status: COMPLETED ·Phase: PHASE2
-
A Crossover Study to Evaluate the Safety, Tolerability and Efficacy of XPF-002 in Subjects With Postherpetic Neuralgia (PHN)
NCT01195636 ·Status: COMPLETED ·Phase: PHASE2
-
RN624 For Pain Of Post-Herpetic Neuralgia
NCT00568321 ·Status: COMPLETED ·Phase: PHASE2
-
To Evaluate the Efficacy and Safety of SR419 in Patients With Postherpetic Neuralgia (PHN)
NCT05357677 ·Status: COMPLETED ·Phase: PHASE2
-
Study of NGX-4010 for the Treatment of Postherpetic Neuralgia
NCT00115310 ·Status: COMPLETED ·Phase: PHASE3
-
Study of NGX-4010 for the Treatment of Postherpetic Neuralgia
NCT00300222 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety and Analgesic Activity of ATx08-001 in Subjects With Postherpetic Neuralgia
NCT01318226 ·Status: COMPLETED ·Phase: PHASE2
-
Multimodal Nerve Block and Pulse Radiofrequency for Acute Herpes Zoster Pain
NCT06798662 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy and Safety Study of SLC022 in Treating Pain Associated With Post Herpetic Neuralgia
NCT00813826 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of ONO-1110 in Patients With Postherpetic Neuralgia
NCT06708416 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Dose-Finding Study of REN-1654 in Patients With Post-Herpetic Neuralgia
NCT00099528 ·Status: UNKNOWN ·Phase: PHASE2
-
New Topical Treatment for Continued Pain After Shingles
NCT00566904 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate the Safety, Tolerability and Pharmacokinetics of BG00010 (Neublastin) Administered to Sciatica Participants
NCT00961766 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of LX9211 in Participants With Postherpetic Neuralgia
NCT04662281 ·Status: COMPLETED ·Phase: PHASE2
-
Study of a Bupivacaine Patch (Eladur™) to Treat Post- Herpetic Neuralgia
NCT00478179 ·Status: COMPLETED ·Phase: PHASE2
-
Analgesic Efficacy and Safety Study of T-62 in Subjects With Postherpetic Neuralgia
NCT00809679 ·Status: TERMINATED ·Phase: PHASE2
-
Injection Therapy for Neuropathic Pain
NCT05809700 ·Status: COMPLETED ·Phase: NA
-
Crossover Post-herpetic Neuralgia (PHN)
NCT01305538 ·Status: COMPLETED ·Phase: PHASE2
-
A Study With Lidocaine 5% Medicated Plaster in Patients Suffering From Postherpetic Neuralgia
NCT03765697 ·Status: COMPLETED ·Phase: PHASE3
-
Duloxetine for PHN
NCT04313335 ·Status: COMPLETED ·Phase: NA
-
Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia
NCT00068081 ·Status: COMPLETED ·Phase: PHASE3